GI Epidemiology: Infection epidemiology and acute gastrointestinal infections

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 6, 2007, Pages 669-674

  O'Brien, S J ^a   Halder, S L S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GASTROENTERITIS; ARTICLE; CLUSTER ANALYSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ECOLOGY; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; METHODOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPATIAL DISCRIMINATION; TIME PERCEPTION;

ACUTE DISEASE; EPIDEMIOLOGIC METHODS; GASTROINTESTINAL DISEASES; HUMANS; INFECTION; TERMINOLOGY;

EID: 33847057222     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03245.x     Document Type: Article

References (16)

1. Giesecke J. Modern Infectious Disease Epidemiology, 2nd edn. London: Arnold, 2002.
2. Mausner JS, Kramer S. Epidemiology - An Introductory Text, 2nd edn. London: WB Saunders, 1985.
3. Wheeler JG, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. Br Med J 1999; 318: 1046.
4. Tam CC, et al. The study of infectious intestinal disease in England: what risk factors for presentation to general practice tell us about potential for selection bias in case-control studies of reported cases of diarrhoea. Int J Epidemiol 2003; 32: 99.
5. Tarr PI, et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073.
6. Innocent GT, et al. Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999. Epidemiol Infect 2005; 133: 1033.
7. Michel P, et al. Temporal and geographical distributions of reported cases of Escherichia coli O157:H7 infection in Ontario. Epidemiol Infect 1999; 122: 193.
8. Nygard K, et al. Association between environmental risk factors and campylobacter infections in Sweden. Epidemiol Infect 2004; 132: 317.
9. Seagroatt V. MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002. Br Med J 2005; 330: 1120.
10. McCarthy N, Giesecke J. Case-case comparisons to study causation of common infectious diseases. Int J Epidemiol 1999; 28: 764.
11. Kaye KS, et al. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005; 26: 346.
12. Gillespie IA, et al. A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. Emerg Infect Dis 2002; 8: 937.
13. Campylobacter Sentinel Surveillance Scheme Collaborators. Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. J Antimicrob Chemother 2002; 50: 561.
14. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144.
15. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health 2000; 21: 193.
16. Haegebaert S, et al. The use of the case-crossover design in a continuous common source food-borne outbreak. Epidemiol Infect 2003; 131: 809.